PharmAla Data to be Published in ACS Chemical Neuroscience
20 févr. 2024 08h55 HE
|
PharmAla Biotech
PharmAla's drug discovery data to be published in ACS Chemical Neuroscience; PharmAla presents data at ISRP Conference in New Orleans
Horseradish Peroxidase Market Set to Reach USD 100 million by 2031, Surging at a 7.3% CAGR - Transparency Market Research, Inc.
19 févr. 2024 09h40 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Feb. 19, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global market for horseradish peroxidase is anticipated to attain a valuation of US$...
In Silico Clinical Trials Market Report 2023-2033 - Expanded Therapeutic Areas Present Lucrative Opportunities
16 févr. 2024 04h09 HE
|
Research and Markets
Dublin, Feb. 16, 2024 (GLOBE NEWSWIRE) -- The "In Silico Clinical Trials Market Report 2023-2033" report has been added to ResearchAndMarkets.com's offering. The in silico clinical trials market...
Life-Science Analytics Market Size is Expected to Surpass the USD 20.9 Billion By 2033; CAGR of 8.0%
12 févr. 2024 07h54 HE
|
Market.Us
New York, Feb. 12, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the Global Life-Science Analytics Market size is projected to exceed USD 20.9 Billion by 2033, and it is poised to reach a...
H1 Honored With Spot On the New York Digital Health 100 For Third Straight Year
08 févr. 2024 09h00 HE
|
H1
NEW YORK, Feb. 08, 2024 (GLOBE NEWSWIRE) -- H1, the leading source of truth for global healthcare professionals, clinical trial, and research information for life sciences, today announced that it...
Global Life Sciences Data Leader H1 Releases GenosAI™ Pro to Empower Clinical Ops Leaders with Conversational AI
07 févr. 2024 09h00 HE
|
H1
NEW YORK, Feb. 07, 2024 (GLOBE NEWSWIRE) -- H1, the leading source of truth for global healthcare professionals, clinical trial, and research information for life sciences, announces the launch of...
Trial of new psychedelic drug seeks patients with Treatment Resistant Depression
07 févr. 2024 04h21 HE
|
Clerkenwell Health
London, Feb. 07, 2024 (GLOBE NEWSWIRE) -- An international clinical trial which is investigating a novel synthetic formulation of the psychedelic substance 5-MeO-DMT (also known as Mebufotenin) for...
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Second Review
06 févr. 2024 07h25 HE
|
ALTERITY THERAPEUTICS LIMITED
- ATH434-201 Trial on Track to Complete in November 2024 – - Top-Line Data Expected in January 2025 - MELBOURNE, AUSTRALIA AND SAN FRANCISCO, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Alterity...
AnaMar Announces US and EU Orphan Drug Designation for AM1476 for Treating Systemic Sclerosis
05 févr. 2024 03h00 HE
|
AnaMar AB
LUND, Sweden, Feb. 05, 2024 (GLOBE NEWSWIRE) -- AnaMar, a clinical-stage biotech company developing first-in-class anti-fibrotic 5-HT2B receptor antagonists, announces that the European Medicines...
Global DLL3 Targeted Therapy Market Research Report 2024 - Innovations, Opportunities, Market Trends & Clinical Trials Insights
01 févr. 2024 03h16 HE
|
Research and Markets
Dublin, Feb. 01, 2024 (GLOBE NEWSWIRE) -- The "Global DLL3 Targeted Therapies Market Opportunities & Clinical Trials Insight 2024" report has been added to ResearchAndMarkets.com's offering. ...